DeepMed Research

The Gynecologic Oncology Group

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1970-01-01

Employees: 11

Market Cap: -

Website: http://www.gog.org

Clinical Trials

Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1

Completed

Conditions: Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2004-06-22

Last Posted Date: 2013-07-09

Lead Sponsor: Gynecologic Oncology Group

Registration Number: NCT00006235

Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Phase 3

Completed

Conditions: Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2004-06-22

Last Posted Date: 2013-05-27

Lead Sponsor: Gynecologic Oncology Group

Target Recruit Count: 324

Registration Number: NCT00002717

Locations: 🇺🇸
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
CCOP - Ann Arbor Regional, Ann Arbor, Michigan, United States

and more 49 locations

Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

Phase 2

Terminated

Conditions: Cervical Cancer
Endometrial Cancer
Fallopian Tube Cancer
Neurotoxicity
Ovarian Cancer
Primary Peritoneal Cavity Cancer
Sarcoma

First Posted Date: 2004-06-16

Last Posted Date: 2013-04-11

Lead Sponsor: Gynecologic Oncology Group

Registration Number: NCT00003624

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
🇺🇸
Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia, United States
🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States

and more 5 locations

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

Phase 2

Completed

Conditions: Endometrial Cancer

First Posted Date: 2004-06-11

Last Posted Date: 2014-01-13

Lead Sponsor: Gynecologic Oncology Group

Registration Number: NCT00085332

Locations: 🇺🇸
CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio, United States

and more 72 locations

Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

Phase 2

Terminated

Conditions: Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2004-06-11

Last Posted Date: 2013-07-09

Lead Sponsor: Gynecologic Oncology Group

Registration Number: NCT00084448

Locations: 🇺🇸
Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, United States

Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers

Phase 2

Completed

Conditions: Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2004-06-10

Last Posted Date: 2013-08-20

Lead Sponsor: Gynecologic Oncology Group

Registration Number: NCT00002538

Locations: 🇺🇸
Walter Reed Army Medical Center, Washington, District of Columbia, United States
🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, United States

and more 8 locations

Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer

Phase 2

Terminated

Conditions: Cervical Cancer
Ovarian Cancer

First Posted Date: 2004-06-09

Last Posted Date: 2013-06-10

Lead Sponsor: Gynecologic Oncology Group

Registration Number: NCT00002478

Locations: 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

and more 44 locations

Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer

Phase 3

Terminated

Conditions: Ovarian Cancer

First Posted Date: 2004-05-26

Last Posted Date: 2013-04-11

Lead Sponsor: Gynecologic Oncology Group

Registration Number: NCT00002819

Locations: 🇺🇸
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States
🇺🇸
Vermont Cancer Center, Burlington, Vermont, United States
🇺🇸
State University of New York - Upstate Medical University, Syracuse, New York, United States

and more 61 locations

Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum

Phase 2

Completed

Conditions: Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2004-05-24

Last Posted Date: 2013-06-21

Lead Sponsor: Gynecologic Oncology Group

Registration Number: NCT00003523

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸
Cleveland Clinic Cancer Center, Cleveland, Ohio, United States

and more 62 locations

Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer

Phase 3

Completed

Conditions: Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2004-05-21

Last Posted Date: 2013-05-27

Lead Sponsor: Gynecologic Oncology Group

Target Recruit Count: 384

Registration Number: NCT00003322

Locations: 🇺🇸
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

and more 64 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy